Hair-removal patent settlement
This article was originally published in The Gray Sheet
Executive Summary
Palomar will earn 5% royalty on Lumenis laser hair-removal device sales in exchange for patent rights to the technology, according a June 22 agreement that ends a legal stalemate between the firms in California and Massachusetts courts. Palomar had alleged that the LightSheer diode laser system and other products violate two patents exclusively licensed from General Hospital Corp. in Boston. Palomar initially developed LightSheer in 1998, then sold the technology to Coherent, acquired by ESC Medical Systems to form Lumenis. Palomar will be paid $4.09 mil. in back-royalties representing the period from July 1, 2002 to Dec. 31, 2003...
You may also be interested in...
Cutera Settles Palomar Hair Removal Laser Suit For $22 Mil. Plus Royalties
Palomar plans to enforce its Anderson patents against additional makers of laser and lamp-based hair removal systems following a successful settlement June 5 with competitor Cutera for $22 mil. plus royalties
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.